Iodine's Immune Sweet Spot: New Review Maps Narrow Window Between Deficiency and Excess

Iodine is essential for making thyroid hormones, but its reach extends far beyond the thyroid gland itself. New research from the University of Guelph and ImmunoCeutica Inc. reveals that this single micronutrient influences immune function across the entire body—and that the difference between a helpful dose and a harmful one is narrower than most nutritional guidelines acknowledge.

The review, published in Nutrients, examined how iodine moves through human and animal tissues and what happens when the body has too little or too much. Iodine transporters exist not just in the thyroid but in bone marrow, the thymus, the spleen, and in circulating immune cells themselves. When iodine levels are adequate, thyroid hormones support natural killer cells and T and B cell responses. Iodine also helps immune cells generate reactive species that kill pathogens and strengthens the body's antioxidant defenses—the cellular machinery that prevents damage from oxidative stress. The picture looks straightforward: enough iodine, healthy immunity.

But the boundary between sufficiency and excess proves difficult to locate. When iodine intake falls too low, immune cells struggle. Neutrophils and macrophages lose their ability to migrate toward infection sites. T cells fail to activate properly. B cells produce weaker antibodies and smaller germinal centers—the structures where immune memory forms. The production of reactive iodine and oxygen species, which are the immune system's chemical weapons against microbes, drops sharply. Deficiency, in short, disarms the immune response.

Sustained excess creates a different problem. High iodine levels trigger excessive iodination inside thyroid cells, generating reactive oxygen species that damage or kill those cells. The dying cells release alarm signals that activate inflammatory pathways, flooding the tissue with interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha. In people with genetic susceptibility—those carrying certain HLA-DR variants or mutations in immune regulators like CTLA4 and PTPN22—this inflammatory cascade can tip into autoimmune thyroiditis, where the immune system attacks the thyroid itself.

The researchers found that current dietary guidelines, set by the Institute of Medicine, Health Canada, and the World Health Organization, focus almost entirely on preventing goiter and neurodevelopmental problems. They measure success by thyroid-centric parameters. What they miss is how iodine intake shapes leukocyte signaling, reactive species generation, and immune competence across the lifespan. The precise intake thresholds that protect immunity while avoiding autoimmune disease remain unmapped.

Animal studies add complexity. In dairy cattle, iodine supplementation improved udder health and enhanced immune cell function. But in pregnant sheep given iodine well above requirements, lambs showed lower antibody levels after nursing, suggesting impaired passive immunity transfer. In dogs, excess iodine caused goiter and hypothyroidism in puppies. In aging cats, chronic excess has been linked to nodular thyroid hyperplasia and hyperthyroidism, though the condition is multifactorial.

The authors emphasize that iodine operates within a narrow physiological window. Too little and the immune system weakens. Too much and it may turn against itself. Yet the exact boundaries differ by species, age, and genetic background. The review calls for longitudinal human studies and controlled animal experiments that measure both exposure and immune function in detail—work that could finally align nutritional guidance with what the immune system actually needs.